Skip to main content

Tagged With "National Prescription Drug Take Back Day"

Survey

Finding Accurate Research Information

AAFA Community Services ·
Please watch this video and answer the following questions. Your responses are anonymous. By answering these questions, you are participating in asthma research! Access to information helps you be an active part of your medical care. But not everything you read is accurate. Learn some basics on how to find information you can trust. Watch video on YouTube Watch the next video in this series - Understanding Research Outcome Measures
Blog Post

10 Health and Medical Organizations Strongly Oppose the Trump Administration’s Plan to Revoke Cleaner Cars Standards

AAFA Community Services ·
“This proposal from EPA and NHTSA would dismantle fair, achievable pollution limits with a track record of success, limits that will help protect Americans from the life-threatening health impacts of climate change. The proposal would also preempt the ability of states to protect the health of their residents by curbing greenhouse gas emissions from vehicles. If these vehicle standards are weakened, the nation loses a crucial tool to fight climate change."
Blog Post

18 Senators Sign Gillibrand-Sheehan “Dear Colleague” Letter Supporting the National Asthma Control Program!

AAFA Community Services ·
Thanks to your efforts, 18 senators signed onto a “Dear Colleague” letter requesting support for a $30-million appropriation in fiscal year 2019 for the National Asthma Control Program (NACP) at the Centers for Disease Control and Prevention (CDC).
Blog Post Featured

2018 Spring Allergies Capitals Report: How Does Your City Rank?

AAFA Community Services ·
As many in the U.S. put away their winter coats, they pull out the allergy medicines. The onslaught of pollen that comes each spring affects millions of Americans with seasonal allergies. The Asthma and Allergy Foundation of America (AAFA) has released the 2018 Spring Allergy Capitals™ report that ranks the top 100 cities in the nation for spring allergies
Blog Post

3 Athletes #TackleAsthma to Help AAFA

AAFA Community Services ·
Asthma feels like an anaconda wrapping around your chest. Every breath hurts and panic sets in. – Kathy, Community Director for the Asthma and Allergy Foundation of America (AAFA), training for a half century (50-mile) bike ride These words used to describe the experience with asthma paint a vivid picture. Despite these moments gasping for air and waiting for the next breath, there are those who conquer great physical challenges. Here are three of their stories. Kathy Przywara, Community...
Blog Post

3 New Studies Shed Light on Penicillin Allergy

AAFA Community Services ·
At some point you may have had a reaction to penicillin and were told you were allergic. And there’s a good chance it has stayed in your chart throughout your childhood and into adulthood. But 9 of 10 Americans who think they have a penicillin allergy have either outgrown it or never had it in the first place. That said, it’s important to get tested by an allergist to know if you have a true penicillin allergy so you know whether to avoid the drug.
Blog Post Featured

Your Game Plan So You Can Exercise Safely with Asthma

AAFA Community Services ·
Rashad Jennings, New York Giants running back, Dr. Neeta Ogden and a team of kids who live with asthma share tips to help people with asthma stay healthy and active.
Blog Post

AAFA Action Alert: Protect Your Health and Keep Access to Health Insurance

AAFA Community Services ·
Congress is rushing to repeal the Affordable Care Act (ACA) without a plan in place to ensure Americans will continue to have access to the insurance they need to stay healthy. Learn how to take action.
Blog Post Featured

AAFA Applauds FDA First Steps Toward Declaring Sesame as Major Allergen

AAFA Community Services ·
The Asthma and Allergy Foundation of America (AAFA), the premiere nonprofit representing patients with asthma and allergies, applauds the recent request for information and statement from the Food and Drug Administration (FDA) demonstrating its commitment to explore the classification of sesame as a major allergen.
Blog Post

AAFA Applauds Senators Grassley and Wyden for Drug Pricing Hearings

AAFA Community Services ·
On behalf of the more than 60 million Americans with asthma and allergies – many of whom depend on life-saving medications – the Asthma and Allergy Foundation of America (AAFA) applauds Senators Chuck Grassley and Ron Wyden for holding hearings on drug pricing in America. This series of hearings demonstrates the senators’ commitment to exploring the problem of overpriced medications in America.
Blog Post

AAFA Applauds Walgreens and Kaléo Partnership, Increasing Patient Access to Life-Saving Epinephrine

AAFA Community Services ·
Walgreens and kaléo, a privately-held pharmaceutical company, are working together to improve access to epinephrine auto-injectors by making kaléo’s AUVI-Q® available through Walgreens locations nationwide. The Asthma and Allergy Foundation of America (AAFA) applauds this effort to help thousands of Americans with their epinephrine needs during the back to school season, as supply issues have been reported to the U.S. Food and Drug Administration (FDA) by other manufacturers.
Blog Post

AAFA CEO Shares Patient Concerns About Restrictions to Allergen Immunotherapy

AAFA Community Services ·
AAFA does not support the changes proposed by USP because we believe they pose a real threat to quality of care. We strongly urge the USP to keep existing guidelines for allergen immunotherapy in place so that millions of patients across the United States can continue to receive the treatment they need.
Blog Post

AAFA Elevates Patient Voice in ICER Review of New Peanut Allergy Treatments

AAFA Community Services ·
On June 11, 2019, in Oakland, California, the Institute for Clinical and Economic Review (ICER) and its California Technology Assessment Forum (CTAF) met to assess the clinical effectiveness and value of treatments for peanut allergy. The review examined two new technologies to induce immune tolerance — Viaskin® Peanut (DBV Technologies) and AR101 (Aimmune Therapeutics) — as well as non-commercialized oral immunotherapy (OIT).
Blog Post

AAFA Explains: Can Herbal Supplements Help My Nasal Allergies?

AAFA Community Services ·
When new drugs and medical procedures are developed, they go through rigorous scientific study. Complementary Alternative Medicine treatments usually do not go through the same type of research. As a result, whether it works (called efficacy) is unproven for most treatments. Most herbal remedies for rhinitis fall into that category.
Blog Post

AAFA Explains: Will Coffee or Caffeinated Drinks Help My Asthma?

AAFA Community Services ·
This post discusses claims that caffeine can be used to treat asthma symptoms. It is part of our “ AAFA Explains ” series looking at complementary and alternative medicine (CAM) aimed at asthma and allergies. The Asthma and Allergy Foundation of America (AAFA) wants to guide you as you decide between choices that may be “likely safe” or “potentially unsafe.” What is asthma? Asthma is a chronic disease that causes your airways to become inflamed, making it hard to breathe. There is no cure...
Blog Post Featured

AAFA Issues Parental Guidance Warning About New Peter Rabbit Film

AAFA Community Services ·
The Asthma and Allergy Foundation of America (AAFA) cautions parents raising children with food allergies that some scenes in the newly-released “Peter Rabbit” film may be disturbing for young viewers with food allergies. In the film, a character with a known food allergy to blackberries is attacked with them. This leads to a severe allergic reaction known as anaphylaxis and the need to use a lifesaving injection of the drug epinephrine.
Blog Post

AAFA Joins 96 Other Patient Groups to Oppose Rule That Would Harm People With Chronic Conditions

AAFA Community Services ·
The I Am Essential coalition, submitted comments, signed by 97 patient groups, to the U.S. Department of Health and Human Services in opposition to the Trump Administration's proposed rule that would expand the scope and applicability of short-term, limited-duration insurance plans (short-term plans). The rule, if finalized, would have a crippling effect on individuals' healthcare.
Blog Post

AAFA Joins Other Patient Groups to Voice Concerns Over Health Care Ruling

AAFA Community Services ·
Access to proper health care coverage is essential and life-saving for people with asthma and allergies. The Asthma and Allergy Foundation of America has joined other patient groups to make up the I Am Essential coalition to advocate against changes that could threaten health care coverage for those we serve. This press release outlines the coalition's concerns about these proposed changes.
Blog Post

AAFA Joins Rashad Jennings Foundation Family Fun Fest

AAFA Community Services ·
July 7-9, 2017, the Rashad Jennings Foundation hosted their annual 180 Weekend in Lynchburg, Virginia. The weekend ended with a Family Fun Fest and Health Expo on July 9. The Asthma and Allergy Foundation of America (AAFA) was honored to host a booth at the event to educate families on asthma.
Blog Post Featured

Plea to the Department of Health and Human Services: People With Allergies Need Access to Epinephrine Now

AAFA Community Services ·
Manufacturing and insurance issues have made it hard for many members of our community to fill their prescriptions for epinephrine auto-injectors in recent months. But the drug epinephrine itself is not in short supply. This has become a serious concern for families of children with life-threatening food allergies. When families who manage food allergies are in fear for their children's lives because they can't get the medicine they need, our system is broken.
Blog Post

AAFA’s Certification Program Expands to Improve Air Quality and Reduce Your Exposure to Allergens

AAFA Community Services ·
In 2017, the asthma & allergy friendly® Certification Program tested and certified many new products to give you more options. When you’re shopping, look for the Certification Program Mark on these new products, as well as our many other products. The mark lets you know you are getting products scientifically proven to be suitable for those with asthma and allergies. You can shop for Certified products by visiting aafa.org/certified or by using our app. Our app is available for both iOS...
Blog Post

AAFA Urges Inclusion of Patient Voice in Analysis of Costly New Asthma Drugs

AAFA Community Services ·
Biologics are a new class of drugs that fight disease at the source . Instead of attacking symptoms, these drugs target diseases like asthma at a molecular level. These newer types of drugs are more expensive than older medicines. That is prompting public discussion on how to pay for them. The cost of caring for patients with the most severe forms of asthma represents a majority of asthma healthcare spending. In addition, asthma is a leading cause of missed time from work and school. Last...
Blog Post

Act Now to Help Protect National Asthma Control Program

AAFA Community Services ·
Congress just cleared its final fiscal year 2018 spending bill. The bill included $29 million for the National Asthma Control Program (NACP). This program is run by the Centers for Disease Control and Prevention (CDC). This important action reverses the president's proposed cut of nearly $4 million to the program. And it actually gives a slight increase to the NACP above what the program got in the 2017 fiscal year.
Blog Post

Advances in Asthma and Allergies in 2019

AAFA Community Services ·
These are just a few things we were able to do this year for the asthma and allergy community because of you. But there is more for us to do to significantly reduce the burden of these diseases on people with asthma and allergies. And we can with your help.
Blog Post

Aerospan Inhaler for Daily Asthma Maintenance Is Being Discontinued

AAFA Community Services ·
According to the Food and Drug Administration (FDA), Mylan is discontinuing Aerospan® (80 mcg). Aerospan is a corticosteroid inhaler used for daily asthma maintenance. Mylan notified the FDA on Jan. 26, 2018.
Blog Post

Albuterol Inhaler Shortage Due to COVID-19 Could Impact People With Asthma

AAFA Community Services ·
The Asthma and Allergy Foundation of America is sharing this message from the American College of Allergy, Asthma and Immunology (ACAAI)for people with asthma about a shortage of albuterol metered dose inhalers
Blog Post

Alert: FDA Requests Removal of All Ranitidine Products (Zantac) From the Market

AAFA Community Services ·
The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac). The agency has determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperature
Blog Post

Ask the Allergist: Does Eczema Affect Allergy Testing?

AAFA Community Services ·
I have eczema and seasonal allergies. My doctor wants to do a skin test to see if I should get allergy shots. Can I get allergy shots if I have eczema? Does eczema affect the accuracy of allergy skin test results?
Blog Post

Ask Your Senators to Approve Increased Funding for the National Asthma Control Program

AAFA Community Services ·
Happy 20th Birthday to the National Asthma Control Program (NACP) of the Centers for Disease Control and Prevention (CDC)! We are thrilled to see that our advocacy efforts are paying off. We applaud the House Appropriations Committee for approving the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Bill, 2020 today to increase to program funding to $34 million. We hope the Senate will do the same.
Blog Post

Asthma and Allergy Caucus to FDA: Take Action to Prevent Albuterol Shortages

AAFA Community Services ·
Congressmen Eliot L. Engel (D-NY) and Fred Upton (R-MI), Co-Chairs of the Asthma and Allergy Caucus, joined by Congressmen TJ Cox (D-CA) and Peter King (R-NY), Members of Caucus, led 57 Members of the House on a letter to the Food and Drug Administration (FDA) about shortages of albuterol inhalers, which are critical to effective asthma management.
Blog Post Featured

Asthma and Allergy Foundation of America Responds to Premature ICER Review of New Peanut Allergy Treatments

AAFA Community Services ·
The Asthma and Allergy Foundation of America (AAFA) addresses concerns regarding the Final Evidence Report assessing the clinical effectiveness and value of treatments for peanut allergy released by the Institute for Clinical and Economic Review (ICER) on July 10, 2019. ICER’s report may cause concern for the allergy community that the findings will restrict access to new treatments for peanut allergy.
Blog Post

AAFA Explains: Can Essential Oils Help Asthma?

AAFA Community Services ·
Essential oils, like herbal remedies, come from plants. Practitioners of traditional and folk medicine (usually meaning those without a medical degree) have used essential oils for thousands of years, much like herbal remedies. Is there any evidence to back up claims that essential oils can help my asthma?
Blog Post

Asthma Drug Shortages During COVID-19: A Letter From AAFA’s President and CEO

AAFA Community Services ·
Because of the COVID-19 (new coronavirus) pandemic, we are facing a challenging and unprecedented time. COVID-19 is a respiratory infection, and the nearly 25 million Americans with asthma are at high risk for complications from the virus. As the leading patient organization for people with asthma and allergies, this has the Asthma and Allergy Foundation of America (AAFA) deeply concerned for your health and well-being.
Blog Post

Asthma Is No Match for Eden’s Winning Attitude

AAFA Community Services ·
Congratulations to PinkLadyCha , the week 2 winner of our #TackleAsthma and #TackleAllergies contest ! Her pictures of her daughter Eden remind us that asthma flareups can strike at any time. But keeping a positive attitude can help you face those tough moments. Eden and her mom will admit that dealing with asthma isn't easy. It can be an emotional and frustrating disease. Her mom describes how hard it can be to watch asthma hold your child back from doing what they love. But they know that...
Blog Post

Back-to-School: Students and Asthma Inhalers

AAFA Community Services ·
Did you know your state allows students to self-carry a quick-relief asthma inhaler while at school? Every state has a policy that allows students in public schools to self-carry, although each has its own procedures. This applies to every state in the U.S. Now is the time of year to get your school forms signed by your child's doctor. These forms include your child's asthma action plan and medication authorization form. Asthma is the leading cause of school absences due to a chronic...
Blog Post

Breathing in the Boat: Dragon Boat World Championships With Asthma

Megan Roberts ·
By Megan Roberts, Community Engagement Program Manager at the Asthma and Allergy Foundation of America I have had exercise-induced bronchoconstriction (asthma) for as long as I can remember. I have also been very active most of my life. Until the end of 2016, one didn’t really affect the other. Pretreating with albuterol before exercise managed all my asthma symptoms. In recent years, as my exercise habits have increased, I haven’t even carried an inhaler at times. At the end of 2011, I...
Blog Post

Breathing in the Boat: The Turnaround Point

Megan Roberts ·
By Megan Roberts, Community Engagement Program Manager at the Asthma and Allergy Foundation of America This post is a follow up to Breathing in the Boat: Dragon Boat World Championships With Asthma . Paddling is my passion. I’ve raced boats in half of the world’s oceans, Hungary, Italy, Hawaii, Canada, Puerto Rico and all over the United States. I have not, however, ever had the opportunity before 2017 to race in China, the birthplace of the sport of dragon boating more than 2,500 years ago.
Blog Post

Breathing in the Boat: It Was All Worth It

Megan Roberts ·
On Oct. 14, 2017, I began my travel across the world to compete at the 13th International Dragon Boat Federation’s Nations World Championships on Dianchi Lake in Kunming, China, after a long and unlikely journey to overcome asthma symptoms that nearly prevented me from competing at all.
Blog Post

Clean Economy Act Would Benefit Millions of People With Asthma and Allergies by Addressing Climate Crisis

AAFA Community Services ·
U.S. Senator Tom Carper (D-Del.), top Democrat on the U.S. Senate Environment and Public Works Committee, was joined by 32 Senators in introducing legislation that would put the United States on a path to achieve net-zero greenhouse gas emissions by no later than 2050.
Blog Post

Congress Recognizes May as National Asthma and Allergy Awareness Month

AAFA Community Services ·
The U.S. House of Representatives has declared their support for National Asthma and Allergy Awareness Month . Reps. Eliot Engel (D-NY), Fred Upton (R-MI), TJ Cox (D-CA) and Peter King (R-NY) submitted the resolution to the House Committee on Energy and Commerce on May 8, 2020. May is peak season for people with asthma and allergies. That’s why the Asthma and Allergy Foundation of America (AAFA) chose it as a time to raise awareness and educate people on how to manage these conditions. Read...
Blog Post

Could Drones Save Lives by Responding to Asthma and Allergy Emergencies?

AAFA Community Services ·
Could drones be used someday to deliver life-saving medications or interventions in the case of a child’s emergency, a drug overdose or in response to a mass casualty scene? According to new research presented at the American Academy of Pediatrics 2019 National Conference & Exhibition, it’s an idea worth exploring.
Blog Post

COVID-19 and Its Impact on People With Asthma and Allergies: A Global Health Crisis

AAFA Community Services ·
The Asthma and Allergy Foundation of America (AAFA) has been fighting to save lives for nearly 70 years. With your support, we provide education, conduct patient-centered research and advocate for protections for our community. Our experience and strong community ties allowed us to take prompt action on the COVID-19 crisis . Thanks to your generous support, we are leading the fight against COVID-19 for people with asthma and allergies. But we need your help to continue to provide COVID-19...
Blog Post

CVS Sinus Relief Nasal Mist Recalled Due to Contamination

AAFA Community Services ·
Holly Hill, FL, Product Quest Manufacturing (“Product Quest”) is voluntarily recalling Lot# 173089J of CVS Health 12 Hour Sinus Relief Nasal Mist, a clear, colorless liquid, to the consumer level. The product was found to have had microbiological contamination identified as Pseudomonas aeruginosa.
Blog Post

Dupilumab Shows Benefit for Those With Severe Asthma During Clinical Trial

AAFA Community Services ·
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the Phase 3 investigational study evaluating dupilumab in adults and adolescents with severe, steroid-dependent asthma met its primary endpoint and key secondary endpoints.
Blog Post

Dupixent® Shows Positive Results in Phase 3 of Trial for Ages 6 to 11 With Severe Atopic Dermatitis

AAFA Community Services ·
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that a pivotal Phase 3 trial evaluating Dupixent® (dupilumab) to treat severe atopic dermatitis in children aged 6 to 11 years met its primary and secondary endpoints. Dupixent is the first and only biologic to show positive results in this pediatric atopic dermatitis population.
Blog Post

Eliminate Allergy and Asthma Triggers From Schools to Support National Healthy Schools Day

AAFA Community Services ·
Asthma is the main reason why children miss school. In fact, children in the U.S. miss about 13.8 million school days each year due to asthma. Missing school can affect many children's grades and well-being. Controlling asthma triggers at home can help reduce asthma symptoms. But what about at school? If kids are exposed to triggers at school, managing asthma at home will be a losing battle. Children are the most affected by air pollution and poor indoor air quality. The Asthma and Allergy...
Blog Post

Facebook Chat: School Accommodations for Food Allergies and Asthma

AAFA Community Services ·
Join the Asthma and Allergy Foundation of America and Kids With Food Allergies for a back-to-school Facebook chat. Attorney, author and food allergy advocate Laurel Francoeur, Esq., will answer your questions on how to send your child with asthma and food allergies back to school with the right accommodations to keep them safe.
Blog Post

FDA Approves a New Treatment Option for Those With Severe Asthma

AAFA Community Services ·
AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has approved Fasenra (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.
Blog Post

FDA Approves Cinqair to Treat Severe Asthma

AAFA Community Services ·
FDA News Release FDA approves Cinqair to treat severe asthma For Immediate Release March 23, 2016 Inquiries Media Andrea Fischer 301-796-0393 Consumers 888-INFO-FDA Release The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current...
Blog Post

FDA Approves Dupixent® for Treatment of Asthma

AAFA Community Services ·
The FDA has approved another biologic treatment, Dupixent, for the treatment of both moderate and severe asthma patients with eosinophilic phenotype and oral corticosteroid-dependent asthma, regardless of phenotype.
 
×
×
×
×